As we transition into 2026, the traditional focus on single-gene mutations is being replaced by multiplex editing protocols that can address multiple genetic drivers of cancer simultaneously. The World Health Organization has recently noted that these "cocktail" genetic interventions are becoming essential for managing heterogeneous tumors that frequently develop resistance to single-target...